CD4 and candidiasis: Although a recent study from Uganda showed that giving fluconazole prophylaxis to those with a CD4 count <200 cells/mm3 can further reduce the impact of candidiasis both pre and post ART [17], it did not reduce overall mortality, and is currently not recommended by WHO [18].